PHARM-SYS LTD 12749673 false 2025-08-01 2026-07-31 2026-07-31 The principal activity of the company is general medical practice activities Digita Accounts Production Advanced 6.30.9574.0 true 12749673 2025-08-01 2026-07-31 12749673 2026-07-31 12749673 core:CurrentFinancialInstruments core:WithinOneYear 2026-07-31 12749673 bus:Micro-entities 2025-08-01 2026-07-31 12749673 bus:AuditExemptWithAccountantsReport 2025-08-01 2026-07-31 12749673 bus:FilletedAccounts 2025-08-01 2026-07-31 12749673 bus:SmallCompaniesRegimeForAccounts 2025-08-01 2026-07-31 12749673 bus:RegisteredOffice 2025-08-01 2026-07-31 12749673 bus:Director1 2025-08-01 2026-07-31 12749673 bus:Director2 2025-08-01 2026-07-31 12749673 bus:PrivateLimitedCompanyLtd 2025-08-01 2026-07-31 12749673 bus:Agent1 2025-08-01 2026-07-31 12749673 countries:AllCountries 2025-08-01 2026-07-31 12749673 2024-08-01 2025-07-31 12749673 2025-07-31 12749673 core:CurrentFinancialInstruments core:WithinOneYear 2025-07-31 iso4217:GBP xbrli:pure

Registration number: 12749673

PHARM-SYS LTD
Unaudited Filleted Financial Statements
for the Year Ended 31 July 2026

PHARM-SYS LTD

Contents

Company Information | 1
Statement of financial position | 2 to 3
Notes to the Unaudited Financial Statements | 2

PHARM-SYS LTD

Company Information

Directors | Mr M R Jillings Mrs J Jillings

Registered office | 2 Hugh Close North Wootton Kings Lynn Norfolk PE30 3ST

Accountants | Hayhow & Co. Chartered Certified Accountants & Business AdvisersUnit 21 Horsley's Fields King's Lynn Norfolk PE30 5DD

PHARM-SYS LTD

(Registration number: 12749673)
Statement of financial position as at 31 July 2026

| 2026 £ | 2025 £
Fixed assets | 639 | 852
Current assets | 13,444 | 15,408
Creditors: Amounts falling due within one year | (1,321) | (1,322)
Net current assets | 12,123 | 14,086
Total assets less current liabilities | 12,762 | 14,938
Accruals and deferred income | (420) | (480)
| 12,342 | 14,458
Capital and reserves | 12,342 | 14,458

1 | General information

The company is a private company limited by share capital, incorporated in UK.

The address of its registered office is:
2 Hugh Close
North Wootton
Kings Lynn
Norfolk
PE30 3ST

These financial statements were authorised for issue by the Board on 10 August 2026.

2 | Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2025 - 2).

For the financial year ending 31 July 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Statement of comprehensive income.

Approved and authorised by the Board on 10 August 2026 and signed on its behalf by:

PHARM-SYS LTD

(Registration number: 12749673)
Statement of financial position as at 31 July 2026

......................................... Mr M R Jillings Director